RULING RESOLUTION Nº 7, of April 27, 2009.

Provides on rules for planned release
into the environment of Risk Class I
Genetically Modified Microorganisms
(GMM) and Genetically Modified
Animals (GMAn) and their derivatives.

THE NATIONAL TECHNICAL BIOSAFETY COMMISSION – CTNBio, using the
powers vested in it and according to applicable regulations, under the provisions
of Article 14(II) of Law nº 11,105, of March 24, 2005, resolves:

CHAPTER 1
GENERAL PROVISIONS
Article 1. The regulations of this Ruling Resolution and other legal
provisions related to the subject of the request, as well as authorizations resulting
from technical decisions issued by CTNBio, apply to the planned release into the
environment of Risk Class I Genetically Modified Microorganisms and Genetically
Modified Animals and their derivatives.
Paragraph 1. The regulations of this Ruling Resolution apply to Risk Class I
Genetically Modified Microorganisms and Genetically Modified Animals and their
derivatives planned to be release into the environment, in Brazil, for the purpose
of experimental assessment.
Paragraph 2. This Ruling Resolution is not applicable to operations under
containment regime, which shall comply with the provisions of CTNBio Ruling
Resolution nº 02, of November 27, 2007.
Paragraph 3. A Genetically Modified Microorganism or a Genetically Modified
Animal that has been granted authorization to be released into the environment
for commercial use shall not be submitted to the provisions of this Ruling
Resolution.
Article 2. For the purpose of this Ruling Resolution the following meanings
apply:
I- Risk Assessment: a combination of procedures or
methods used to assess, on a case by case basis, the
potential effects of a planned release of a Genetically
Modified Microorganism or a Genetically Modified Animal
and their derivatives to the environment and human and
animal health;
II- Genetically Modified Microorganism (GMM) – a
microorganism the genetic material (DNA/RNA) of which
has been modified by any genetic engineering technique;
III- GMM derivative – a product obtained from a GMM that is
unable to autonomously replicate itself or fails to contain
a viable form of Genetically Modified Microorganism;
IV- Genetically Modified Animal (GMAn) – an animal the
genetic material (DNA/RNA) of which has been modified
by any genetic engineering technique;
V- GMAn derivative – a product obtained from a GMAn that
is unable to autonomously replicate itself or fails to
contain a viable form of GMAn;
VI- Applicant: any legal entity, holder of a Quality Certificate
in Biosafety – CQB, intending to conduct a planned
release, according to this Ruling Resolution;
VII- Person Legally in Charge – individual responsible for
conducting the planned release under CTNBio rules;
VIII- Risk – probability of an adverse event;
IX- Planned release – release into the environment of a GMM
or a GMAn and their derivatives, for monitored
experimental assessment, under the provisions of this
Ruling Resolution.
Article 3. An authorization for planned release into the environment of a
GMM or GMAn may be suspended or revoked by CTNBio at any time in case
adverse effects on the environment or human and animal health are detected or
otherwise in the light of fresh scientific knowledge.
Article 4. The Applicant shall keep an individual follow-up record of the
GMM or GMAn planned release into the environment including, without limitation,
details or practices used in the experiment and biosafety measures applied.
Article 5. The Person Legally in Charge of the applying legal entity and the
respective CIBio are in charge of securing compliance with the provisions of this
Ruling Resolution in what concerns the planned release of a GMM or GMAn and
their derivatives into the environment.
Paragraph 1. CTNBio shall be notified of any failure in complying with the rules
of this Resolution and with the biosafety procedures and measures established by
CTNBio in the technical opinion related to the planned release.
Article 6. Any accidental release of a GMM or GMAn and their derivatives
shall be promptly notified to CIBio and CTNBio. CIBio shall forward to CTNBIO,
within five (5) days, a report on corrective actions taken, including the names of
the individuals and authorities who have been notified.
Paragraph 1. The notification mentioned in this Article 6 does not exempt the
Applicant to inform the competent authorities and individuals who may be
exposed, with a view to adoption of applicable measures, according to the
legislation in effect.
CHAPTER II
DOCUMENTATION OF THE APPLICATION
Article 7. Following approval by CIBio, the applicant shall submit the
proposal to CTNBio accompanied by:
I - Application for Planned Release: Information on the institution,
dated and executed by the Person Legally in Charge, according
to Annex I hereof;
II - Information on the GMM or GMAn and their derivatives, according
to Annex II hereof;
III - Information on the GMM or GMAn and their derivatives Planned
Release, according to Annex III hereof;
IV - Maps and Sketches for the Planned Release of the GMM or
GMAn and their derivatives, according to Annex IV hereof;
V - CIBIO authorization for importing material, as the case may be.
Paragraph 1. The application shall be submitted in the Portuguese language, in
four conformed counterparts, accompanied by a copy in electronic support.
Article 8. CTNBio shall take the necessary measures to safeguard the
confidential information of commercial interest identified by the applicant and
considered as such by CTNBio, provided such information does not attract
private or collective interests protected by the Brazilian Constitution.
Paragraph 1. In order to maintain the confidentiality mentioned in this Article 8,
the applicant shall forward to the President of CTNBio an express and well
grounded request containing specifications on the information to be kept
confidential.
Paragraph 2. The request may be dismissed through a well grounded order,
which may be subject to appeal to CTNBio plenary meeting, and confidentiality
shall be maintained until a final decision is reached to the contrary.
Paragraph 3. The appeal shall be filed within fifteen (15) days from the date the
decision is published in the Federal Official Gazette and shall be examined by a
CTNBio plenary meeting within sixty (60) days.
Paragraph 4. The Applicant may select to withdraw its proposal in case the
request for confidentiality is definitely dismissed and, in this case, CTNBio may
not disclose the information for which confidentiality has been sought.
Article 9. Registration and monitoring bodies and entities may request
access to certain confidential information deemed to be indispensable to such
body or entity in a petition explaining the request and indicating the agent that
may have access to the confidential information.
Paragraph 1. Registration bodies and entities may not disclose any confidential
information.
Article 10. The proposal for planned release filed with CTNBio Executive
Secretariat, after being processed and duly documented, shall have a Previous
Summary published in the Federal Official Gazette, within thirty (30) days.
Paragraph 1. In case importing a GMM or GMAn is necessary for conducting
the planned release into the environment, the Applicant shall forward the CIBIO
authorization, together with the proposal of the planned release, for joint
examination by CTNBio.
Article 11. Each proposal shall be examined by not less than two CTNBio
Permanent Sector Sub-commissions.
Paragraph 1. The Permanent Sector Sub-commissions shall have a joint term
of not less than ninety (90) days to examine and prepare their opinions, which in
turn shall be submitted to CTNBio plenary meeting for approval of the planned
release.
Article 12. CTNBio may request additional information and new documents,
which shall be answered by the applicant within sixty (60) days from the date of
receipt of the relevant notification, under the penalty of the application being filed
as cancelled.
Article 13. Within ten (10) days from approval by CTNBio, a summary of the
technical decision shall be published in the Federal Official Gazette.
Article 14. Within six (6) months from the completion of a planned release,
the CIBio of the applying institution shall forward to CTNBio a detailed report
according to Annex V hereof.
CHAPTER III
RISK ASSESSMENT AND FINAL PROVISIONS
Article 15. Risk assessment, as defined in Article 3(I) hereof, shall identify
and assess potential adverse effects of a GMM or GMAn and their derivatives,
while maintaining transparency, scientific method and the principle of precaution.
Article 16. Cases not foreseen by this Resolution shall be settled by CTNBio.
Article 17. The provisions hereof apply to applications to planned release
into the environment of Genetically Modified Microorganisms and Genetically
Modified Animals and their derivatives filed with CTNBio after this Resolution
becomes effective.
Article 18. CTNBio Ruling Instruction nº 3, of November 12, 1996, Ruling
Instruction nº 5, of January 08, 1997, Ruling Instruction nº 10, of February 19,
1998 and Ruling Instruction nº 16, of October 30, 1998 are hereby revoked.
Article 19. This Ruling Resolution shall be effective upon publication.

Walter Colli
President of CTNBio

ANNEX I
APPLICATION FOR PLANNED RELEASE OF GENETICALLY MODIFIED
MICROORGANISMS OR GENETICALLY MODIFIED ANIMALS AND THEIR
DERIVATIVES
INFORMATION ON THE APPLYING INSTITUTION
1. Name of Institution in Charge;
2. Address for contact with CIBio;
3. Name, title and address of the Person Legally in Charge and the Chief
Technician;
4. CIBio opinion, including comments on the ability of the Chief Technician
to manage the works, adequacy of experimental plan contained in the
proposal, selection of location and emergency security plan;
5. Statement for the purpose that "The information contained in this
document is, to the best of my knowledge, complete, accurate and true".
(name and signature of the Person Legally in Charge, and date);
6. CIBio endorsing statement: "CIBio has assessed and endorses this
proposal" (name, date and signature of the President of CIBio); and
7. Name and signature of the Person Legally in Charge, and date.

ANNEX II
INFORMATION ON THE GMM or GMAn
1. Information on the species of Genetically Modified Microorganism or
Genetically Modified Animal to be released (include, as appropriate,
scientific name, subspecies, lineage, etc.);
2. Information on genetic modifications introduced and their consequences;
3. Information on vector used and methodology of transformation;
4. Description of exogenous DNA/RNA sequence, indicating the regulating
elements that may be present;
5. Indication of one or more markers (phenotypic, cytogenetic or molecular)
that enable identification of the GMM or GMAn;
6. Information on number of proceedings approved by CTNBio of which the
current proposal is a sequel;
7. Description of genetic characteristics of the GMM or GMAn that may
affect their survival in the environment;
8. Information on measures taken to contain gene flow;
9. Description on how survival of the GMM or GMAn will be monitored at the
location of the planned release;
10. Information on whether the release relates to GMM or GMAn, as well as
type of derivative, its composition, degradability, possible toxic or
allergenic effect.

ANNEX III
INFORMATION ON THE PLANNED RELEASE OF THE GMM OR GMAn AND
THEIR DERIVATIVES
1. Title of proposal;
2. Purpose of the proposal;
3. Address of the proposed location where the planned release is to be
conducted;
4. Procedures for transporting the GMM or GMAn and their derivatives to
the location of the planned release, indicating their origin;
5. Experimental protocol for the planned release and monitoring during the
experiment – include biosafety and discarding procedures, information on
the size of the total area of GMM or GMAn and their derivatives planned
release;
6. Information on the date foreseen for starting the planned release;
7. Information on the date foreseen for the completion of the planned
release;
8. Description of supervision procedures for the area of planned release and
safety procedures to be conducted by the persons in charge;
9. CIBio shall make a list of individuals in charge for developing the
experiment and describe the training given to staff members, together
with a letter informing the installation of the experiment;
10. Information on whether there will be or not a transfer or sending of
material for analysis or storage by another unit and what will the
destination be;
11. Information on whether the planned release is likely to affect the
characteristics or abundance of other species, and how this will be
monitored;
12. In case the GMM or GMAn and their derivatives remain in the
environment after the planned release experiment, inform: length in time
and possible consequences, and the monitoring to be conducted; and
13. Measures to be taken to remove the GMM or GMAn and their derivatives
in case of any evident threat occurs during the planned release
experiment.

ANNEX IV
MAPS AND SKETCHES FOR THE PLANNED RELEASE INTO THE
ENVIRONMENT OF A GMM OR GMAn AND THEIR DERIVATIVES
1. Name of Municipality and State;
2. Name of property and property's owner;
3. Full address of the property, telephone, fax and electronic address;
4. Sketch, indicating the name of the main highway of access to the
property, reference to the nearest city identifying the entrance to the
property, kilometer of reference for entering the property and
secondary/feeder road;
5. Map of the area accredited by CQB, including:
- Map size and scale used. Inform cartographic (nominal and
graphic) scale, orientation by compass card and by geographic
and topographic coordinates, as the case may be, of the
experimental area.
- Indication of any existing improvements;
- Identification of boundaries of CQB accredited area;
- Identification of permanent protection areas and legal reserve;
- Indication of water bodies (rivers, rivulets, natural and artificial
lakes, dams);
6. Location of the experiment, including geographic coordinates, within the
area accredited by CQB. In case it proves necessary to change the
location, within the same area accredited by CQB and under CTNBio
rules, the applicant shall inform the exact location within fifteen (15) days
from the establishment of the experiment.

ANNEX V
FINAL REPORT ON GMM OR GMAn PLANNED RELEASE INTO THE
ENVIRONMENT
1. Institution;
2. Number of CQB;
3. Number of Release Proceedings;
4. Name of CIBio President and CIBio address;
5. Title of Proposal;
6. Chief Technician;
7. Person Legally in Charge;
8. Released GMM or GMAn and their derivatives;
9. Risk classification;
10. Genetic modifications introduced and consequences;
11. Releases foreseen;
12. Released conducted;
13. Place of release;
14. Date of beginning;
15. Date of completion;
16. Biosafety measures adopted and whether such measures were in line
with the CTNBio Technical Opinion;
17. Monitoring procedures used and whether such measures were in line with
the CTNBio Technical Opinion;
18. Information on survival of the GMM or GMAn and their derivatives at the
location of the release after completion of the experiment;
19. Submission of a summary of results achieved and whether the objectives
of the planned release were attained;
20. Report on any unexpected effects recorded during the planned release; and
21. Information on whether the competent body supervised the experiment,
including a copy of the Supervision Report and the Violation Record, as
the case may be.
Date:
Signature of CIBio President.
Signature of the Chief Technician.

Approves the Internal Regulation of the National Biosafety
Council – CNBS.

THE PRESIDENT OF THE NATIONAL BIOSAFETY COUNCIL – CNBS, in
the use of her attributions and due to Plenary decision, at
meeting on January 29th, 2008, decides:

Art.1. The Internal Regulations of the National Biosafety
Council – CNBS are approved, according to this Resolution
Attachment.
Art. 2. This Resolution is in force from its date of
publication.

DILMA ROUSSEFF

INTERNAL REGULATION OF THE NATIONAL BIOSAFETY COUNCIL- CNBS

CHAPTER I
THE OBJECTIVE AND THE COMPOSITION OF CNBS
Art. 1. The National Biosafety Council – CNBS, a collegiate
organ that takes part of the structure of the Presidency of
the Republic, created by article 8 of Law No. 11.105, of
March 24th, 2005, and regulated by Decree No. 5.591, of
November 22nd, 2005, aims at, among other things, the
higher assistance to the President of the Republic for the
formulation and implementation of the National Policy of
Biosafety.
Art. 2. CNBS is composed by the following members:
I – State Ministry Head of the Civil Cabinet of the
Presidency of the Republic, who will preside it;
II – State Ministry of Science and Technology;
III – State Ministry of Agrarian Development;
IV – State Ministry of Agriculture, Cattle Breading and
Supply;
V – State Ministry of Justice;
VI – State Ministry of Health;
VII – State Ministry of the Environment;
VIII – State Ministry of Development, Industry and Foreign
Trade;
IX – State Ministry of Foreign Affairs;
X - State Ministry of Defense; and
XI – Special Secretary of Aquiculture and Fishing of the
Presidency of the Republic.
Paragraph 1. The members of CNBS will be substituted, in
their absences or hindrances, by the Executive-Secretaries
of the respective Ministries, or, if there is no such an
office, by the substitutes of the State Ministry of the
Special Secretary.
Paragraph 2. In the President's absence, he will appoint
the State Ministry to preside the works.

CHAPTER II
CNBS' COMPETENCE
Art. 3. It is CMBS's responsibility:
I – to assist the President of the Republic on the
formulation and implementation of the National Policy of
Biosafety;
II – stipulate principles and policies for the
administrative action of federal organs and entities with
competences on the matter;
III – at request from the National Technical Biosafety
Commission – CTNBio, regarding the aspects of living and
socio-economical opportunity, and of the national interest,
analyze the requests of release for the commercial use of
genetically modified organisms – GMO, and its derivatives;
and
IV – based on CTNBio's manifestation and when it deems
necessary, out of the organs and entities referred to on
art. 16 of Law No. 11.105, of 2005, in the ambit of ther
competences, claim and decide, in last and definite
jurisdiction, about the process regarding the activities
that involve the commercial use of GMO and its derivatives.

CHAPTER III
CNBS' MEMBERS' ATTRIBUTIONS
Art. 4. CNBS' Members' attributions are:
I – to zeal for the full and total development of CNBS
attributions;
II – to analyze and report, within pre-established terms,
subjects distributed to it;
III – to appreciate, and whenever it is the case,
deliberate about subjects presented to CNBS;
IV – to request from CNBS President, the voting of subject
in urgency character, and the request should be submitted
to Plenary Approval; and
V – perform other activities that are necessary to the
fulfillment of its attributions and to the functioning of
CNBS.

CHAPTER IV
THE ORGANIZATION AND THE FUNCTIONING OF CNBS
Section I
The General Dispositions
Art. 5. CNBS has the following internal organization:
I – Plenary;
II – Presidency; and
III – Executive-Secretariat.
Subsection I
The Plenary
Art. 6. The Plenary is the decisive instance of CNBS,
composed by members appointed on art. 2, and it will meet
through calling or provocation, in accordance with the
requisites of functioning established on this Internal
Regulation.
Subsection II
The Plenary Functioning
Art. 7. CNBS will meet through calling from its President
or through provocation of most of its members.
Paragraph 1. CNBS calling provocation referred to on the
caput should be founded, explicating the motives and the
meeting agenda.
Paragraph 2. On the document calling the meeting, the
President will record the agenda, the date, the time and
the place the session will take place.
Art. 8. CNBS sessions will only take place with the
presence of at least six members, and the decisions will be
taken with favorable votes from the absolute majority.
Art.9. On CNBS sessions, the following procedures will be
adopted:
I – works installations by the President;
II – checking of the presence and existence of quorum for
the collegiate installation;
III – reading and approval of the previous meeting minutes;
IV – reading of general information, when it is the case;
V – presentation, discussion and deliberation of subjects
on the agenda; and
VI – closing of the works.
Art.10. Alteration of subjects on record will take place
through CNBS' President's decision or by proposition of any
of the members, as long as it is approved by the Plenary.
Subsection III
The Processes
Art. 11. The processes will be processed at the Executive-
Secretariat of CNBS, and the term for the respective
judgment will start from this date.
Sole Paragraph. The process receipt registration will
indicate the date and sole number of protocol.
Art.12. CNBS' competence processes distribution shall be
made by the President.
Art.13. After distributing the process, the reporter member
will write the report, and submit it to CNBS' judgment.
Art. 14. After the reporter's vote, CNBS' President should
open a discussion period for the subject, for its members'
judgment.
Sole Paragraph. After consulting the Plenary, the President
will determine the closing of oral debate, and open for
voting.
Art.15. The President will proclaim the result, whose final
decision will be written by the Executive-Secretariat.
Sole Paragraph. CNBS' deliberations will be constituted of:
I – propositions: when there is higher assistance to the
President of the Republic on the formulation and
implementation of the National Policy of Biosafety;
II – guidance: when there is stipulation of principles and
policies for the administrative action of federal organs
and entities; and
III – resolutions: when there is final decision about the
analysis, at CTNBio's request, regarding the aspects of
convenience and socio-economical opportunity, and of
national interest, of release requests for commercial use
of GMO and its derivatives, appeal and decision, in last
and definite jurisdiction, of the processes regarding
activities that involve the commercial use of GMO and its
derivatives, and judgment of resources interposed by
registration and inspection organs and entities.
Art.16. At every CNBS' meeting minutes will drawn up,
which, after being approved and signed by he present
members, will be filed at the Executive-Secretariat.
Art.17. The final decision will only be effective from its
publication date, by the Executive-Secretariat, at the
Official Gazette.
Art. 18. The President or CNBS may requested urgency on the
appreciation of a subject on the agenda.
Art.19. The President or the Executive–Secretariat will be
able to request manifestation from the Sub-office for
Juridical Subjects, and from the Sub-office of Analysis and
Follow-up of Governmental Policies at the Civil Cabinet of
the Presidency of the Republic, in the ambit of its
competences, to subsidize CNBS' decisions.
Art.20. The requests, requirements or resources that do not
fit on the legal hypotheses of CNBS' competence, are, at
preliminary order, not granted by the President ad
referendum of CNBS.
Sub-section IV
The Executive-Secretariat
Art.21. It is the Executive-Secretariat's responsibility,
together with the Civil Cabinet of the Presidency of the
Republic:
I – to zeal for the full development of CNBS' attributions;
II – to plan, organize, and coordinate CNBS' technical and
administrative activities;
III – to provide the necessary means for CNBS' works
execution;
IV – to promote the handling of processes subject to CNBS'
deliberation;
V – to forward CNBS' manifestation to the registration and
inspection organs and entities referred to on art. 16 of
Law No. 11.105, of 2005, whenever there is final decision
in favor of the execution of the analyzed activity;
VI – to forward CNBS' manifestation to CTNBio for the
petitioner's awareness, whenever there is final decision
against the analyzed activity;
VII – to assist CNBS' members in issues of the Council's
competence;
VIII- to request manifestation from the Sub-office of
Juridical Subjects and from the Sub-office of Analysis and
Follow-up of Governmental Policies of the Civil Cabinet of
the Presidency of the Republic, in the ambit of its
competences, to subsidize CNBS' decisions; and
IX – to execute other attributions determined by CNBS'
President.
Section II
The Specific Dispositions of Process of CNBS' Competence
Sub-Section I
The Analysis of Convenience and Opportunity
Art.22. CNBS will decide, at CTNBio's request, about
convenience and socio-economical opportunity aspects, and
of national interest on the release for commercial use of
GMO and its derivatives.
Paragraph 1. CTNBio should enter in a protocol, with CNBS'
Executive-Secretariat, the process regarding the activity
to be analyzed, or its integral copy, indicating motives
for such forwarding.
Paragraph 2. After the processing of CTNBio's request, CNBS
Executive-Secretariat shall send to the members of the
Council, within five days, a copy of the request, of the
motivation, and of CTNBio's technical decision, and it will
make the process available for eventual consultation or
copy requests.
Sub-section II
The Processes Appeal
Art.23. CNBS shall appeal to a higher court the processes
regarding the activities that involve the commercial use of
GMO and its derivatives for analysis and decision, in last
and definite jurisdiction, within thirty days from the date
of publication of CTNBio's technical decision on the
Official Gazette.
Paragraph 1. In case of appeal, the Executive-Secretariat
will notify CTNBio so that it remits to CNBS the process
that was appealed to higher court, or its full copy, within
five days.
Paragraph 2. Within five days, the Executive-Secretariat
will send to CNBS' members, contacts of the registration of
the copy of the process, a copy of CTNBIo's technical
decision, and it will make the process available for
eventual consultations or copy requests.
Subsection III
Registration and Inspection Organs and Entities Resources
Art.24. CNBS will decide about the registration and
inspection organs and entities resources regarding the
commercial liberation of GMO and its derivatives, which
have entered in a protocol in its Executive-Secretariat,
within thirty days counting from the date of publication of
CTNBio's technical decision on the Official Gazette.
Paragraph 1. The resource dealt with in this article shall
be instructed with technically founded justification that
demonstrates the divergences of the registration and
inspection organ or entity, in the ambit of their
competences regarding CTNBio's decision in relation to
biosafety aspects of GMO and its derivatives.
Paragraph 2. After the resource has entered in the protocol
referred to on the caput, CNBS Executive-Secretariat will
request from CTNBio the process, or its full copy, within
five days.
Paragraph 3. Within five days, CTNBio shall send to CNBS
the process, or its full copy.
Paragraph 4. After having received the process, or its full
copy, within five days, CNBS Executive-Secretariat shall
send to the Council's members a copy of the resource, and
of the appealed technical opinion, and it will make the
process available for consultations and requests of copies
by CNBS' members.
Paragraph 5. Within the period foreseen on paragraph 4,
CNBS Executive-Secretariat will send to CTNBio a copy of
the interposed resource.
Paragraph 6. The untimely resources will not be granted by
the President at preliminary order.

CHAPTER V
THE FINAL DISPOSITIONS
Art. 25. CNBS will publicize its activities and decisions,
except for secret information, of public, commercial or
business interest.
Sole Paragraph. Requests for certificates and copies of
processes pieces shall be directed by the interested party
to CTNBio, who will make the process available for
consultation or copy, observing the secrecy of the
documents and information in accordance with Decree No.
5.591, of 2005.
Art.26. The participation on CNBS' activities will be
considered relevant function, not remunerated.
Art.27. The proposal for this Internal Regulation
alteration shall be presented by any member at a CNBS
session.
Sole Paragraph. This Internal Regulation alteration will
only be approved by favorable vote of the majority of CNBS'
members.
Art.28. The missing cases and the doubts arising on the
application of this Internal Regulation will be solved by
CNBS' President, ad referendum of the Council.
Sole Paragraph. The President or CNBS may request
manifestation of the Sub-office for Juridical Issues and
the Sub-office of Analysis and Follow-up of Governmental
Policies of the Civil Cabinet of the Presidency of the
Republic, in the ambit of their competences, to subsidize
the resolution of missing cases, and of doubts arising from
the application of this Internal Regulation.